Current management of onychomycosis - An overview

Onychomycosis is a common condition, particularly among men and the elderly. The management of onychomycosis can be divided into topical and oral antifungal agents and surgical therapy. During the past few years, three new oral antimycotics-itraconazole, terbinafine, and fluconazole-have had increasing use for the treatment of onychomycosis. These agents have a favorable adverse effect profile and appear to be more cost-effective than griseofulvin. They have resulted in the shortening of the treatment duration for onychomycosis, particularly pedal disease.